Researchers developed a hybrid quantum-classical AI system that designed immune-targeting peptides, with quantum-generated inputs.

Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help underserved populations and combat rare diseases.

Researchers developed a hybrid quantum-classical AI system that designed immune-targeting peptides, with quantum-generated inputs.